CGC
Price
$1.05
Change
+$0.03 (+2.94%)
Updated
Apr 2 closing price
Capitalization
784.64M
57 days until earnings call
CRON
Price
$1.82
Change
+$0.03 (+1.68%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
1B
40 days until earnings call
Ad is loading...

CGC vs CRON

Header iconCGC vs CRON Comparison
Open Charts CGC vs CRONBanner chart's image
Canopy Growth
Price$1.05
Change+$0.03 (+2.94%)
Volume$4.86M
Capitalization784.64M
Cronos Group
Price$1.82
Change+$0.03 (+1.68%)
Volume$17.11K
Capitalization1B
CGC vs CRON Comparison Chart
Loading...
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGC vs. CRON commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGC is a StrongBuy and CRON is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (CGC: $1.05 vs. CRON: $1.81)
Brand notoriety: CGC: Notable vs. CRON: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CGC: 54% vs. CRON: 62%
Market capitalization -- CGC: $784.64M vs. CRON: $1B
CGC [@Pharmaceuticals: Other] is valued at $784.64M. CRON’s [@Pharmaceuticals: Other] market capitalization is $1B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGC’s FA Score shows that 0 FA rating(s) are green whileCRON’s FA Score has 0 green FA rating(s).

  • CGC’s FA Score: 0 green, 5 red.
  • CRON’s FA Score: 0 green, 5 red.
According to our system of comparison, CRON is a better buy in the long-term than CGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGC’s TA Score shows that 5 TA indicator(s) are bullish while CRON’s TA Score has 3 bullish TA indicator(s).

  • CGC’s TA Score: 5 bullish, 3 bearish.
  • CRON’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CGC is a better buy in the short-term than CRON.

Price Growth

CGC (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while CRON (@Pharmaceuticals: Other) price change was +0.56% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.71%. For the same industry, the average monthly price growth was -0.38%, and the average quarterly price growth was -8.58%.

Reported Earning Dates

CGC is expected to report earnings on May 30, 2025.

CRON is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.71% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRON($1.01B) has a higher market cap than CGC($785M). CRON YTD gains are higher at: -10.396 vs. CGC (-61.679). CRON has higher annual earnings (EBITDA): -71.8M vs. CGC (-1.02B). CRON has more cash in the bank: 862M vs. CGC (186M). CRON has less debt than CGC: CRON (2.55M) vs CGC (693M). CGC has higher revenues than CRON: CGC (362M) vs CRON (87.2M).
CGCCRONCGC / CRON
Capitalization785M1.01B78%
EBITDA-1.02B-71.8M1,424%
Gain YTD-61.679-10.396593%
P/E RatioN/AN/A-
Revenue362M87.2M415%
Total Cash186M862M22%
Total Debt693M2.55M27,145%
FUNDAMENTALS RATINGS
CGC vs CRON: Fundamental Ratings
CGC
CRON
OUTLOOK RATING
1..100
6963
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9885
PRICE GROWTH RATING
1..100
9780
P/E GROWTH RATING
1..100
10059
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRON's Valuation (57) in the Pharmaceuticals Other industry is somewhat better than the same rating for CGC (93) in the Agricultural Commodities Or Milling industry. This means that CRON’s stock grew somewhat faster than CGC’s over the last 12 months.

CRON's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that CRON’s stock grew similarly to CGC’s over the last 12 months.

CRON's SMR Rating (85) in the Pharmaceuticals Other industry is in the same range as CGC (98) in the Agricultural Commodities Or Milling industry. This means that CRON’s stock grew similarly to CGC’s over the last 12 months.

CRON's Price Growth Rating (80) in the Pharmaceuticals Other industry is in the same range as CGC (97) in the Agricultural Commodities Or Milling industry. This means that CRON’s stock grew similarly to CGC’s over the last 12 months.

CRON's P/E Growth Rating (59) in the Pharmaceuticals Other industry is somewhat better than the same rating for CGC (100) in the Agricultural Commodities Or Milling industry. This means that CRON’s stock grew somewhat faster than CGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CGCCRON
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 17 days ago
79%
Bullish Trend 17 days ago
73%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 8 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 6 days ago
73%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BGATX15.760.12
+0.79%
Baillie Gifford Global Alpha Equities 2
TWQAX14.49N/A
N/A
Transamerica Large Cap Value A
WCMLX11.43N/A
N/A
WCM Small Cap Growth Institutional
FPCSX40.23N/A
N/A
FPA Crescent Supra Institutional
JABFX12.27N/A
N/A
JHancock Real Estate Securities C